The CMO position has become increasingly important to any psychedelics company and its future success. The post New Psychedelics Hybrid: Chief Medical...
Cybin (NYSE American: CYBN | NEO: CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics(R), today issued a year-end summary...
The article Top 5 Psychedelic Milestones of 2022 was originally published on Microdose. As we turn the final pages of 2022, it’s important to take a...
Marc B. Aixalà’s Psychedelic Integration might be an answer to the Greek myth, so sincere and thoroughgoing is its quest for answers to grief over one's...
Bioregnum Opinion Column by John Carroll Roche let the air out of the TIGIT party balloon with a pair of crushing Phase III failures. Now Gilead...
The article California Introduces New Bill to Decriminalize Psychedelics was originally published on Microdose. California is once trying to decriminalize...
AbbVie has secured its fourth FDA approval for Vraylar, adding adjunctive therapy of major depressive disorder (MDD) to The post AbbVie claims key approval...
It is currently as good a time as ever for long-term investors to buy stocks. With that in mind, I decided to look for seven cheap...
As psychedelic-assisted therapies near FDA approval, questions remain about cost, who's paying, and how much it saves patients and insurers in the long...
The article Gilgamesh Pharmaceuticals Raises $39 Million in Series B Financing was originally published on Microdose. Gilgamesh Pharmaceuticals has announced...
Lipstick can be a confidence booster, enhance a costume and keep lips from chapping. But sharing a tube with a friend or family member can also...
New cybersecurity company focused on AI & ML introduces an industry-first tool to secure millions of Jupyter Notebooks and accelerate the industry...
It has been quite a year for the psychedelics industry. We’ve experienced our fair share of ups and downs, opportunities and uncertainties, and a great...
The article Breaking News: Quebec First Province to Cover Costs of Psilocybin Therapy was originally published on Microdose. Quebec doctors have successfully...
Company also closed a C$3 million capital raise. The post Psyence Gets Rights For Psilocybin Drug For Palliative Care appeared first on Green Market R...